Table 1 Clinical characteristics of reports with immune checkpoint inhibitors from the FAERS database (January 2004 to September 2024).
Characteristics | Case number, n | Case proportion, % |
|---|---|---|
Number Of Events | 2022 | |
Weight | ||
< 50 Kg | 54 | 2.5 |
> 100 Kg | 67 | 3.0 |
50 ~ 100 Kg | 328 | 14.9 |
Missing | 1753 | 79.6 |
Age | ||
≤ 17 | 13 | 0.6 |
≥ 86 | 7 | 0.3 |
18 ~ 64 | 412 | 18.7 |
65 ~ 85 | 668 | 30.3 |
Missing | 1102 | 50.0 |
Reporter’s type of occupation | ||
Consumer | 1167 | 53.0 |
Health-professional | 284 | 12.9 |
Physician | 651 | 29.6 |
Other health-professional | 37 | 1.7 |
Pharmacist | 60 | 2.7 |
Missing | 3 | 0.1 |
Serious Outcome | ||
Death | 206 | 9.4 |
Disability | 23 | 1.0 |
Hospitalization - Initial or Prolonged | 386 | 17.5 |
Life-Threatening | 32 | 1.5 |
Other Serious (Important Medical Event) | 468 | 21.3 |
Missing | 1087 | 49.4 |
Reporter’s Country (Top Five) | ||
United States | 1674 | 76.0 |
Japan | 101 | 4.6 |
France | 73 | 3.3 |
Korea, South | 70 | 3.2 |
Canada | 42 | 1.9 |
